Mannkind (MNKD) Goodwill & Intangibles (2022 - 2026)
Mannkind (MNKD) reported Goodwill & Intangibles of $72.6 million for Q1 2026, up 915.93% year-over-year from $7.1 million in Q1 2025, and little changed on a QoQ basis from $72.7 million in Q4 2025.
Mannkind (MNKD) has 5 years of Goodwill & Intangibles data on file, last reported at $72.6 million in Q1 2026.
- Quarterly Goodwill & Intangibles rose 915.93% year-over-year to $72.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.6 million (up 915.93% YoY) and the FY2025 annual result came in at $72.7 million, up 909.82% from the prior year.
- Goodwill & Intangibles held at $72.6 million in Q1 2026 per MNKD's latest filing, from $72.7 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $72.7 million in Q4 2025 and bottomed at $3.0 million in Q2 2024.
- The 5-year median for Goodwill & Intangibles is $4.3 million (2022), against an average of $13.2 million.
- The widest annual swing landed in 2023, when Goodwill & Intangibles decreased 29.21%; it then jumped 915.93% in 2026.
- Tracing MNKD's Goodwill & Intangibles over 5 years: stood at $3.1 million in 2022, then retreated by 1.6% to $3.0 million in 2023, then jumped by 139.55% to $7.2 million in 2024, then soared by 909.82% to $72.7 million in 2025, then slipped by 0.07% to $72.6 million in 2026.
- Per Business Quant, the three latest MNKD Goodwill & Intangibles figures stand at $72.6 million (Q1 2026), $72.7 million (Q4 2025), and $7.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.62 Mn |
| Dec 31, 2025 | 72.67 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 7.15 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 7.21 Mn |
| Jun 30, 2024 | 2.96 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 3.05 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 4.30 Mn |